Literature DB >> 12831072

Principles of treatment for osteosarcoma.

Melissa Endicott1.   

Abstract

Canine osteosarcoma accounts for 5% to 6% of all canine malignancies. A thorough workup is recommended to help clients make an educated decision about treatment options. Patients should be screened for concurrent diseases and early metastasis, as part of the diagnostic workup. Diagnostic techniques have improved to allow for more biopsy options. Once osteosarcoma is confirmed, there are many treatment options, both definitive and palliative, which can be offered to an owner. Amputation is no longer the only option that we can offer as treatment. Limb-sparing surgeries have become more common, and techniques in chemotherapy have significantly improved the median survival time in patients. Even if surgery is not an option, there are alternatives available to provide pain control and good quality of life. It is important to be versed in all the options to provide clients with the best possible recommendations.

Entities:  

Mesh:

Year:  2003        PMID: 12831072     DOI: 10.1053/svms.2003.36626

Source DB:  PubMed          Journal:  Clin Tech Small Anim Pract        ISSN: 1096-2867


  3 in total

1.  Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.

Authors:  Laura Bongiovanni; Francesca Mazzocchetti; Daniela Malatesta; Mariarita Romanucci; Andrea Ciccarelli; Paolo Buracco; Raffaella De Maria; Chiara Palmieri; Marina Martano; Emanuela Morello; Lorella Maniscalco; Leonardo Della Salda
Journal:  BMC Vet Res       Date:  2012-06-11       Impact factor: 2.741

2.  Long-term Formation of Aggressive Bony Lesions in Dogs with Mid-Diaphyseal Fractures Stabilized with Metallic Plates: Incidence in a Tertiary Referral Hospital Population.

Authors:  Robert S Gilley; Elizabeth Hiebert; Kemba Clapp; Lara Bartl-Wilson; Michael Nappier; Stephen Werre; Katherine Barnes
Journal:  Front Vet Sci       Date:  2017-01-31

3.  Expression and regulatory effects of microRNA-182 in osteosarcoma cells: A pilot study.

Authors:  Dong-Lin Bian; Xue-Mei Wang; Kun Huang; Qi-Xi Zhai; Gui-Bo Yu; Cheng-Hua Wu
Journal:  Oncol Lett       Date:  2016-03-23       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.